Literature DB >> 15128808

Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network.

Andrés Vazquez-Torres1, Bruce A Vallance, Molly A Bergman, B Brett Finlay, Brad T Cookson, Jessica Jones-Carson, Ferric C Fang.   

Abstract

Mammalian cells recognize LPS from Gram-negative bacteria via the Toll-like receptor 4 (TLR4) complex. During experimental Salmonella infection, C3H/HeJ mice carrying a dominant-negative mutation in TLR4 exhibited delayed chemokine production, impaired NO generation, and attenuated cellular immune responses. However, dramatically enhanced bacterial growth within the Kupffer cell network before the recruitment of inflammatory cells appeared to be primarily responsible for the early demise of Salmonella-infected TLR4-deficient mice. LPS-TLR4 signaling plays an essential role in the generation of both innate and adaptive immune responses throughout the course of infection with Gram-negative bacteria. Alternative pattern-recognition receptors cannot completely compensate for the loss of TLR4, and compensation occurs at the expense of an increased microbial burden.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128808     DOI: 10.4049/jimmunol.172.10.6202

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

1.  Caveolin-1 protects against sepsis by modulating inflammatory response, alleviating bacterial burden, and suppressing thymocyte apoptosis.

Authors:  Hong Feng; Ling Guo; Zhiqing Song; Haiqing Gao; Dan Wang; Weisi Fu; Jingyan Han; Zhenyu Li; Bin Huang; Xiang-An Li
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  TRIF mobilizes unique primary defense against Gram-negative bacteria in intestinal interface.

Authors:  John Sotolongo; Saravana Kanagavelu; Jinhee Hyun; Jose Ruiz; Masayuki Fukata
Journal:  Gut Microbes       Date:  2012-06-20

3.  Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis.

Authors:  Scott L Friedman
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

4.  Immunogenicity of cytopathic and noncytopathic viral vectors.

Authors:  Gabriela Plesa; Philip M McKenna; Matthias J Schnell; Laurence C Eisenlohr
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Toll-Like receptor 2 (TLR2) and TLR9 play opposing roles in host innate immunity against Salmonella enterica serovar Typhimurium infection.

Authors:  Renhui Zhan; Qiuju Han; Cai Zhang; Zhigang Tian; Jian Zhang
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

6.  DksA-dependent resistance of Salmonella enterica serovar Typhimurium against the antimicrobial activity of inducible nitric oxide synthase.

Authors:  Calvin A Henard; Andrés Vázquez-Torres
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

7.  Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.

Authors:  Mohammed A Khan; Caixia Ma; Leigh A Knodler; Yanet Valdez; Carrie M Rosenberger; Wanyin Deng; B Brett Finlay; Bruce A Vallance
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

8.  Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells.

Authors:  Hongmei Li; Catherine Matte-Martone; Hung Sheng Tan; Srividhya Venkatesan; Jennifer McNiff; Anthony J Demetris; Dhanpat Jain; Fadi Lakkis; David Rothstein; Warren D Shlomchik
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

Review 9.  Salmonella infection: Interplay between the bacteria and host immune system.

Authors:  Jonathan R Kurtz; J Alan Goggins; James B McLachlan
Journal:  Immunol Lett       Date:  2017-07-15       Impact factor: 3.685

10.  Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection.

Authors:  Antonella Marangoni; Manuela Donati; Francesca Cavrini; Rita Aldini; Silvia Accardo; Vittorio Sambri; Marco Montagnani; Roberto Cevenini
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.